Latest scientific news
Published in Nature
Published in EMBO Reports
Published in Communications Chemistry
Image
Shilpa Biocare invests in Gate2Brain to advance an innovative therapeutic candidate for brain cancer
Gate2Brain, an IRB Barcelona spin-off, signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake in the company.
Image
Ona Therapeutics raises $86.6 M Series B to advance first-in-class ADCs into clinical development
The financing supports Ona Therapeutics, an IRB Barcelona and ICREA spin-off, in its transition to a clinical-stage company.
Image
HelixAI: New spin-off from IRB Barcelona, ICREA, and UPC to transform biomedical data into clinical insight using AI
HelixAI, the ninth spin-off for IRB Barcelona, integrates multi-omic data to drive both biomedical research and clinical practice.
Image
Two open Group Leader positions
IRB Barcelona invites applications for two Group Leader positions, one in Chemical Biology and one in Structural Biology, as part of its strategic effort to strengthen the molecular sciences.
Image
Cancer doesn't wait campaign
IRB Barcelona launches the Cancer doesn't wait campaign to raise funds for cancer and metastasis research.
Upcoming Events
Upcoming Events
